XENETIC BIOSCIENCES, INC.

Profile

Company Names

XENETIC BIOSCIENCES, INC.

Addresses

945 CONCORD ST., FRAMINGHAM, MA 01701

40 SPEEN STREET, SUITE 102, FRAMINGHAM, MA 01701

Phone Numbers

781-778-7720

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$17,591,843.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-10-12 
$488,835.00 
$488,835.00 
$0.00 
Equity 
4
2022-04-26 
$866,250.00 
$866,250.00 
$0.00 
Equity 
3
2021-07-28 
$12,500,000.00 
$12,500,000.00 
$0.00 
Equity 
2
2019-07-03 
$251,508.00 
$251,508.00 
$0.00 
Equity 
1
2019-03-05 
$3,485,250.00 
$3,485,250.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GRIGORY 
 
BORISENKO 
DIRECTOR
ADASTRA PHARMACEUTICALS, INC.   |  ATEA PHARMACEUTICALS, INC.   |  XENETIC BIOSCIENCES, INC.
JAMES 
 
CALLAWAY 
DIRECTOR
XENETIC BIOSCIENCES, INC.
FIRDAUS 
 
DASTOOR 
DIRECTOR
XENETIC BIOSCIENCES, INC.
JEFFREY 
 
EISENBERG 
EXECUTIVE OFFICER, DIRECTOR
CALISTOGA HOTEL GROUP, LP   |  EP HAMMS, LLC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  XENETIC BIOSCIENCES, INC.
DMITRY 
 
GENKIN 
DIRECTOR
XENETIC BIOSCIENCES, INC.
ROMAN 
 
KNYAZEV 
DIRECTOR
XENETIC BIOSCIENCES, INC.
ROGER 
 
KORNBERG 
DIRECTOR
COCRYSTAL DISCOVERY INC   |  BIOZONE PHARMACEUTICALS, INC.   |  SENSOR-KINESIS CORP   |  COGNOS THERAPEUTICS INC   |  XENETIC BIOSCIENCES, INC.   |  AUTONOMOUS MEDICAL DEVICES INC   |  NEOTX HOLDINGS LTD.
CURTIS 
 
LOCKSHIN 
EXECUTIVE OFFICER, DIRECTOR
QUIKBYTE SOFTWARE INC   |  CHROMADEX CORP.   |  RXI PHARMACEUTICALS CORP   |  XENETIC BIOSCIENCES, INC.
ADAM 
 
LOGAL 
DIRECTOR
VBI VACCINES INC/BC   |  XENETIC BIOSCIENCES, INC.
JAMES 
 
PARSLOW 
EXECUTIVE OFFICER
WORLD ENERGY SOLUTIONS, INC.   |  XENETIC BIOSCIENCES, INC.
ALEXEY 
 
VINOGRADOV 
DIRECTOR
TEARSOLUTIONS, INC.   |  XENETIC BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2022-10-12 
2022-05-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2022-04-26 
2021-08-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2021-07-28 
2019-07-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-07-03 
2019-03-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2019-03-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
MAXIM GROUP LLC
12078